Seelos Therapeutics SEEL
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 9.55 | -181.13 | 18.24 | -3,139 | 2 | |
| 2024Q1 | 75.65 | 229.27 | -25.60 | -6,055 | -3 | |
| 2023Q4 | 177.92 | 147.42 | 9.06 | -8,011 | -5 | |
| 2023Q3 | 706.57 | -119.57 | 349.34 | -12,603 | 10 | |
| 2023Q2 | 4588.85 | 37.14 | -889.60 | -10,953 | -29 | |
| 2023Q1 | 2654.23 | 66.54 | -458.24 | -8,932 | -13 | |
| 2022Q4 | 2607.39 | 97.86 | -657.72 | -18,257 | -19 | |
| 2022Q3 | 3955.24 | 88.82 | -729.67 | -17,410 | -20 | |
| 2022Q2 | 2612.38 | 99.87 | -768.08 | -21,239 | -21 | |
| 2022Q1 | 3217.18 | 100.11 | -499.25 | -14,010 | -14 | |
| 2021Q4 | 6259.26 | 100.44 | -1075.21 | -27,374 | -27 | |
| 2021Q3 | 9254.49 | 101.07 | -345.60 | -10,910 | -11 | |
| 2021Q2 | 10137.70 | 81.85 | -307.20 | -6,773 | -9 | |
| 2021Q1 | 19161.79 | 91.65 | -1075.21 | -16,612 | -19 | |
| 2020Q4 | 6067.26 | 92.79 | -499.21 | -5,845 | -6 | |
| 2020Q3 | 3598.12 | 100.02 | -307.20 | -4,085 | -4 | |
| 2020Q2 | 3878.44 | 89.10 | -307.20 | -3,320 | -4 | |
| 2020Q1 | 1883.54 | 114.11 | -537.61 | -5,509 | -5 | |
| 2019Q4 | 5145.65 | 96.92 | -1036.81 | -10,330 | -11 | |
| 2019Q3 | 3525.16 | 114.32 | 960.01 | -3,681 | -3 |